• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.52%

    Puma Biotechnology, Inc. (PBYI)

    -NYSE
    227.85 Down 7.55(3.21%) Apr 17, 4:01PM EDT
    |After Hours : 229.08 Up 1.23 (0.54%) Apr 17, 4:12PM EDT
    Add to Portfolio
    Prev Close:235.40
    Open:233.86
    Bid:228.04 x 100
    Ask:228.66 x 400
    1y Target Est:276.80
    Beta:-1.99
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:225.00 - 235.00
    52wk Range:53.63 - 279.37
    Volume:292,222
    Avg Vol (3m):295,429
    Market Cap:7.27B
    P/E (ttm):N/A
    EPS (ttm):-4.73
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for PBYI

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-5.34
    Quarterly EPS Est (Mar-15) :-1.33
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.12

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Puma Biotechnology, Inc., a development stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of products for the treatment of various forms of cancer. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback